US FDA clears AbbVie-Genmab’s Epkinly for relapsed or refractory DLBCL
The approval was based on results from the Phase 1/2 EPCORE NHL-1 trial, which enrolled 157 patients with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 May 23
The approval was based on results from the Phase 1/2 EPCORE NHL-1 trial, which enrolled 157 patients with…
22 May 23
CureVac is filing counterclaim in U.S. court under nine patents covering foundational mRNA innovations highly relevant to the…
22 May 23
The MAA is based on the results of the confirmatory Phase III Clarity AD study and Phase IIb…
19 May 23
The Pin-point system and the underlying base editing technology are intended to allow efficient and precise single and…
19 May 23
Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide
16 May 23
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium…
15 May 23
The smallest mistake in a surgical procedure can leave patients with injuries that lessen their quality of life,…
12 May 23
Under the agreement, both firms will develop therapies using J-Brain Cargo, blood-brain-barrier penetrating technology, to treat epilepsy by…
12 May 23
The Finnish medical imaging company Planmed is introducing Planmed XFI – the world’s first full-body weight-bearing CT. The…
11 May 23
The approval was based on two late-stage studies, which revealed significant improvement in calming agitated patients with Alzheimer's…